ftInvstr
MANKIND · Healthcare ₹2655.4 +2.81% Mkt Cap ₹110281 Cr undervalued

MANKIND

Healthcare Drug Manufacturers - Specialty & Generic
₹2655.4
+2.81% today · 30d +12.01%
as of 2026-11-09
Price · Daily Candles
AI narrative is temporarily unavailable for MANKIND. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-09-30
REVENUE
₹4338 Cr
+17.33% YoY
NET PROFIT
₹716 Cr
+37.67% YoY
OPM
28.56%
+1.82pp YoY
EPS
₹17.23
PE 49.04
Intrinsic value · DCF ₹4793.41 · Margin of safety +80.5% (undervalued) · FCF yield 2.26%
◇ Sector Position
PEERPEROCE %
MANKIND49.0414.0
SUNPHARMA37.7921.44
DIVISLAB93.121.56
ZYDUSLIFE28.424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
68
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 75
Valuation FAIR 40
Growth STEADY 61
Profitability HIGH 75
Technicals NEUTRAL 65
Risk LOW 90
Key Stats
TTM PE
49.04
P/B
6.25
52W HIGH
₹2705.0
OFF HIGH
-1.83%
DIV YIELD
0.0%
MKT CAP
₹110281 Cr
◉ Active Signals
MACDBullish25.8135
RSI(14)Bullish68.69
Near 52W HighBullish-1.83
Street Consensus
19 analysts
₹2703.26
mean target
Low ₹2057.0Now ₹2655.4High ₹3280.0
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold MANKIND and at what entry.

Sign up freeSign in